3 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Country: Ireland
×
Brand Name: Cellex Photopheresis System Product Name: CELLEX Photopheresis Kit Model/Catalog Number: CLXUSA Software Version: Not Applicable Product Description: THERAKOS Photopheresis or extracorporeal photopheresis (ECP) is a photoimmune therapy where leukocytes are separated from whole blood via apheresis, combined with a photoactive drug (8-methoxypsoralen) and then exposed to ultraviolet A (UVA) light. All blood components, including the treated leukocytes, are returned to the patient. THERAKOS¿ Photopheresis utilizes the THERAKOS CELLEX System to combine cell separation and photoactivation into a single, closed and sterile circuit. The THERAKOS CELLEX Photopheresis System collects the buffy coat (leukocyte-enriched blood) from the patient in a discontinuous flow process and intermittently returns the remaining plasma and erythrocytes to the patient. The buffy coat is passed through the photoactivation module where the drug is activated with a precise amount of UVA light determined by the characteristics of the individual patient s buffy coat. After photoactivation, the buffy coat is immediately returned to the patient s bloodstream. Component: Not Applicable
FDA Enforcement
Class II
·Ongoing·THERAKOS DEVELOPMENT LIMITED·April 22, 2026
THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA
FDA Enforcement
Class II
·Ongoing·Mallinckrodt Pharmaceuticals Ireland Ltd·February 16, 2022
E C REP LIMITED
Authorized representative
🇮🇪 Ireland·15 Manufacturers·1499 Devices